CSI Market
Sign In | Register

The Chemours (CC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CC Annual Cash Flow →
A period-by-period view of cash flow from The Chemours to Jun 30 2025 helps clarify how Jun 30 2026's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-303.00
Depreciation & amortization159.00
Amortization of Other Assets5.00
Write-down of investments0.00
Restructuring Costs and Asset Impairment Charges10.00
Provision For Loan Losses Expensed24.00
Increase (Decrease) in Inventories and Other Operating Assets-114.00
Share-based plans166.00
Gain (Loss) on Disposition of Assets, Total266.00
Share-based Compensation-1.00
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions10.00
Gains (Losses) on Extinguishment of Debt-11.00
Defined Benefit Plan Contributions-1.00
Income taxes0.00
Losses/ -gains on investments net0.00
Increase (Decrease) in Accounts and Notes Receivable461.00
Increase (Decrease) in Accounts Payable-12.00
Accrued expenses0.00
Other receivables0.00
Financing valuation provision0.00
Other Working Capital286.00
Prepaid expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-832.00
Discontinued operations0.00
Net Cash flow from Operating Activities114.00
Investing Activities
Capital Expenditures-93.00
Sale of Capital Items294.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Payments for (Proceeds from) Derivative Instrument, Investing Activities-7.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Purchases of Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Repayments of Accounts Receivable Securitization0.00
Proceeds from Life Insurance Policies1.00
Other Net-5.00
Discontinued operations0.00
Net Cash Flow from Investing Activities195.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-16.00
Long-term debt - borrowings700.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock3.00
Proceeds from Contributions from Parent0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net-2.00
Other net-967.00
Proceeds from Payments of Contributionsto Parent-
Proceeds From Payments Of Contributions To Parent-
Proceeds From Issuance Of Long Term Debt Excluding Lines Of Credit-
Repayments Of Long Term Debt Excluding Lines Of Credit-689.00
Finance Lease Principal Payments-3.00
Deferred Acquisition Related Considerations-
Proceeds From Supplier Financing Programs16.00
Payments To Supplier Financing Programs-14.00
Dividends paid to minority interests0.00
Dividends paid-26.00
Net Cash Flow from Financing Activities-308.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow315.00
Total Cash Flow-1.00
4 historic quarters locked

Sign in to unlock the full The Chemours cash flow history.

Sign In Create Free Account

About Chemours Co Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 5, 2026
  • Source: cc-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001627223-26-000024

Figures are derived from filed reports and may be restated. Historical data is subject to revision.